Medicare Part D cliff ahead
By Juliet Johnson | June 21, 2018
Medicare Part D has been providing seniors with access to prescription drug coverage that meets their needs for more than a decade. Today, more than 42 million people are enrolled in Part D and 90...
Read More
Patients with a deductible have seen their out-of-pocket costs for brand medicines increase 50 percent since 2014
By Holly Campbell | June 20, 2018
Spending on medicines is growing at the slowest rate in years, but according to a new IQVIA Institute for Human Data Science article, at the pharmacy, commercially insured patients with a...
Read More
ICYMI - Analysis finds higher outpatient drug spending at 340B hospitals
By Nicole Longo | June 18, 2018
Did you know 340B hospitals prescribe more medicines or more expensive medicines? A recent analysis by Milliman, commissioned by PhRMA, found hospitals participating in the 340B drug pricing...
Read More
Part D cliff looms for seniors, as program stability could be in jeopardy
By Juliet Johnson | June 18, 2018
For more than a decade, Medicare Part D has successfully provided seniors comprehensive prescription drug coverage that meets their needs, while its market-based structure has kept overall program...
Read More
By
Despite the current unprecedented pace of biopharmaceutical innovation, patients continue to face rising out-of-pocket costs and other barriers to care. Tomorrow, in partnership with The Atlantic,...
Read More
Sharing negotiated discounts at the pharmacy counter could save seniors with diabetes more than $350 annually
By Holly Campbell | May 17, 2018
Sharing a portion of negotiated rebates at the pharmacy counter could save seniors in Medicare with diabetes more than $350 annually, according to a new analysis from IHS Markit. The data also...
Read More
New “Let’s Talk About Medicare” campaign focuses on solutions to improve affordability and predictability for seniors in Part D
By Juliet Johnson | May 9, 2018
Today, we are launching the “Let’s Talk About Medicare” advertising campaign focused on solutions to improve affordability and predictability for seniors in Medicare Part D. Similar to how the “...
Read More
Video: PhRMA CEO discusses biopharmaceutical supply chain at POLITICO event
By Holly Campbell | May 4, 2018
Yesterday, PhRMA president and CEO Stephen J. Ubl spoke at POLITICO’s “Deconstructing the Prescription Drug Supply Chain” event, discussing the incredible new era of medicine, medicine spending...
Read More
Event tomorrow: Making the biopharmaceutical supply chain work for patients
By Katie Koziara | May 2, 2018
In the U.S. health care system, the complex process of delivering medicines to patients is highly intermediated and involves many entities, including insurance companies, pharmacy benefit managers...
Read More
Reality check: Value-based contracts are good for patients
By Michelle Drozd | April 25, 2018
Biopharmaceutical companies are joining stakeholders across the health care system to pursue flexible ways to pay for medicines that focus on results, lower out-of-pocket costs and enable patients...
Read More
Medicare Monday (100)
340B Spotlight (35)
Cost & Consequence (0)
